Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
RAVE Restaurant Group
RAVE
$43.2M
| $455K | ﹤0.01% |
204,122
-7,981
| -4% | -$18.2K |
|
2827
Barclays
BCS
$94.7B
| $454K | ﹤0.01% |
57,586
-782,700
| -93% | -$5.64M |
|
2828
Smartbird Inc
BIRD
$30.1M
| $454K | ﹤0.01% |
18,520
-6,070
| -25% | -$120K |
|
|
CLSD
2829
DELISTED
Clearside Biomedical
CLSD
| $450K | ﹤0.01% |
25,646
+7,427
| +41% | +$106K |
|
2830
GEE Group
JOB
$27M
| $449K | ﹤0.01% |
897,392
-64,308
| -7% | -$35K |
|
|
CCRN
2831
DELISTED
Cross Country Healthcare
CCRN
| $448K | ﹤0.01% |
19,786
-165,044
| -89% | -$3.58M |
|
2832
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $448K | ﹤0.01% |
6,000
+1,200
| +25% | +$82K |
|
2833
JPMorgan BetaBuilders Japan ETF
BBJP
$19.1B
| $446K | ﹤0.01% |
+8,500
| New | +$432K |
|
2834
Willamette Valley Vineyards
WVVI
$11.5M
| $444K | ﹤0.01% |
82,952
-1,600
| -2% | -$8.58K |
|
|
NEUE
2835
DELISTED
NeueHealth
NEUE
| $444K | ﹤0.01% |
58,163
+1,600
| +3% | +$10.8K |
|
|
ACHL
2836
DELISTED
Achilles Therapeutics
ACHL
| $444K | ﹤0.01% |
498,995
+61,467
| +14% | +$52.7K |
|
|
EMKR
2837
DELISTED
Emcore Corp
EMKR
| $444K | ﹤0.01% |
90,890
+2,810
| +3% | +$12.5K |
|
2838
Schwab Fundamental US Small Company Index ETF
FNDA
$9.45B
| $443K | ﹤0.01% |
16,000
-15,400
| -49% | -$382K |
|
2839
ProShares Short High Yield
SJB
$47.6M
| $443K | ﹤0.01% |
25,700
-25,400
| -50% | -$462K |
|
2840
Gyre Therapeutics
GYRE
$708M
| $439K | ﹤0.01% |
17,085
-22,294
| -57% | -$316K |
|
2841
Franklin Financial Services
FRAF
$288M
| $438K | ﹤0.01% |
+13,897
| New | +$438K |
|
2842
KLX Energy Services
KLXE
$35.3M
| $437K | ﹤0.01% |
38,800
-6,300
| -14% | -$63.8K |
|
|
SEMR
2843
DELISTED
Semrush
SEMR
| $436K | ﹤0.01% |
31,900
-64,800
| -67% | -$640K |
|
2844
USCB Financial Holdings
USCB
$415M
| $435K | ﹤0.01% |
35,500
+17,300
| +95% | +$197K |
|
2845
Nuvectis Pharma
NVCT
$618M
| $432K | ﹤0.01% |
51,800
+26,400
| +104% | +$235K |
|
2846
Chesapeake Utilities
CPK
$3.26B
| $428K | ﹤0.01% |
4,050
-16,200
| -80% | -$1.54M |
|
2847
Palomar
PLMR
$3.37B
| $427K | ﹤0.01% |
7,694
-4,706
| -38% | -$263K |
|
2848
Invesco S&P 500 Pure Growth ETF
RPG
$2.1B
| $426K | ﹤0.01% |
+13,200
| New | +$404K |
|
|
VZLA
2849
Vizsla Silver
VZLA
$1.32B
| $426K | ﹤0.01% |
341,152
+188,299
| +123% | +$205K |
|
2850
Ark Restaurants
ARKR
$20.2M
| $425K | ﹤0.01% |
30,211
-500
| -2% | -$7.61K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.